Tsvetoslav Georgiev

Rheumatologist dealing with the mysteries of 🦴 and #autoimmune disorders. AP at @muvarna_bg, 🩺 at St. Marina, EiC at RBJ & AE at RHEI. Views are my own.

[Tsvetoslav Georgiev @GeorgievMD]

A notable shift in the new EULAR recommendations: imaging SpA is no longer just diagnostic.
MRI and ultrasound can help monitor activity, predict outcomes and guide treatment in SpA. #Rheumatology #EULAR2026

[Daliya Pencheva @daliyapencheva]

🤩 A nice surprise to see our poster featured by @lupus_hub after today’s presentation at #EULAR2026🇬🇧 #lupus #SLE #eularEMEUNET

[Lupus Europe @LupusEurope]

👏 Congratulations to all recipients of the @eular_org Abstract Awards!

#EULAR2026

[Rheumatology (Bulgaria) @BulgarianR]

Evaluating the real-world performance of Upadacitinib in Rheumatoid Arthritis. 🧪
A retrospective study in Bulgaria demonstrates robust therapeutic efficacy and a favorable safety profile over a 6-month period. Full text: https://t.co/JZQusR48Zj
#Rheumatology #RealWorldEvidence

[Tsvetoslav Georgiev @GeorgievMD]

Great to be part of this international effort, with a small contribution to a much bigger team project.

[EMEUNET @EMEUNET]

🎥 Meet Jorge Álvarez Troncoso @joraltron, one of the EMEUNET Top 10 Abstract winners at EULAR 2026!
📍 Don’t miss his presentation in London on Thur. 4 June 2026, 8:55 - 9:05, George V Room 3!

#eularEMEUNET #emeunettop10abstracts #EULAR2026 congress

[NatRevRheumatol @NatRevRheumatol]

New content online: Treat-to-target in Behçet syndrome https://t.co/kOrIFzT2Bm

[RMD Open @bmj_rmdopen]

🦴 Spinal ligaments in #SpA: can ultrasound help?

This study developed and validated a landmark-based US protocol for thoracolumbar ligaments:
✅ Lateral costotransverse ligament
✅ Supraspinous ligament
✅ Iliolumbar ligament

In healthy controls, visualisation was feasible and reliability was moderate to high.
In patients with SpA, US detected inflammatory and structural entheseal lesions.
A new window for assessing axial inflammation beyond conventional imaging.

🔓 https://t.co/Trdc7aD6Fe

[RMD Open @bmj_rmdopen]

VEDOSS vs pre-#SystemicSclerosis: boundaries remain blurred.

This scoping review found major variability in how very early diagnosis of systemic sclerosis and pre-SSc are defined.

✅ 40 original articles included
✅ 3 definitions of pre-SSc identified
✅ 13 different applications of VEDOSS criteria
✅ Only 31.3% applied the complete VEDOSS definition
✅ Some studies included patients with visceral or fibrotic complications, challenging the “very early” concept

A consensus definition of pre-SSc is needed to support risk stratification and future preventive trials.

🔓 https://t.co/uhQofaGNv9

[NEJM @NEJM]

Inflammatory myopathies are typically associated with a myositis-specific autoantibody that determines the diagnosis and prognosis. Myositis subgroups have distinct pathomechanisms that now allow for targeted therapies.

Learn more in the Review Article “Inflammatory Myopathies” by Yves Allenbach, MD, PhD, and Olivier Benveniste, MD, PhD: https://t.co/ZeCKdNe87v

[Armen Yuri Gasparyan @ArmenYuri]

MANUSCRIPTS WITH FAKE CHATGPT-CREATED REFERENCES: A CASE STUDY | Cent Asian J Med Hypotheses Ethics
@dr_emrebilgin @NeslihanGken7 @sadouslu @abdulvahap_md @DDoskaliuk @Birzhan7101423 @ZaferKocak14 @KasapcopurOzgur @Tati03153937 @KardumZeljka
https://t.co/V0LB8Z7Gxx

[Rheumatology (Bulgaria) @BulgarianR]

🚀 Rheumatology (Bulgaria) is entering a new era. New platform, renewed Editorial Board, higher standards. We welcome high-quality rheumatology research.
📩Submit now. #Rheumatology #OpenScience
https://t.co/kigQmi8cWm

[Tsvetoslav Georgiev @GeorgievMD]

How did I almost miss the new EULAR recommendations for Behçet’s syndrome? A major 2025 update, from colchicine/apremilast to TNF inhibitors in severe organ disease and, tellingly, TNF is mentioned 79 times! https://t.co/9xNws7tC4M

[RMD Open @bmj_rmdopen]

🆕 Development and validation of SONAR-7: a novel ultrasound score for synovitis

Ultrasound is increasingly central to the evaluation of inflammatory arthritis, but feasibility and standardisation remain key challenges. This study introduces SONAR-7, a concise composite score designed for patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).

🔍 What stands out:

Integrates greyscale and power Doppler findings across 14 joints
Demonstrates high specificity (95.1%) with good overall discrimination (AUC 0.83)
Shows consistent associations with:
Clinical disease activity (e.g. swollen joint count, DAPSA)
Enthesitis burden
Functional outcomes (HAQ, BASMI)

💡 Beyond inflammation, the inclusion of structural changes strengthens its clinical relevance, linking imaging findings with patient-reported and functional measures.

📊 Overall, SONAR-7 emerges as a pragmatic and time-efficient tool, with potential utility in both routine practice and research settings across the spondyloarthritis spectrum.

📎 https://t.co/Bxivpgjvkt

[Armen Yuri Gasparyan @ArmenYuri]

Pregnancy planning in women with rheumatic diseases: an integrated framework for risk stratification and multidisciplinary management
@OlenaZimba @YuliyaFedorchen @KaWegiel68670 @ZofiaGula @Mattkliw @JarosawNowakow6 @yogadoctornikki @NeslihanGken7
https://t.co/UsS1B5mNco

[Rheumatology (Bulgaria) @BulgarianR]

Can SI joint injections improve outcomes in axSpA? 💉🦴 A randomized trial evaluating ultrasound-guided steroid and lidocaine effects on MRI scores and clinical disease activity measures. Full text: https://t.co/7CVdBtT9pj
#Rheumatology #axSpA #ClinicalTrial

[Rheumatology (Bulgaria) @BulgarianR]

What is the real-world retention rate of Upadacitinib in Rheumatoid Arthritis? A multicenter study found a 74.7% retention rate at 12 months. Persistence was significantly higher in seropositive (RF+/ACPA+) patients. Full text: https://t.co/icb1eGF4m7
#Rheumatology #JAKinhibitors

[Tsvetoslav Georgiev @GeorgievMD]

Not all endothelial markers behave the same in spondyloarthritis. In our study, VCAM-1 tracked inflammatory activity and treatment status, especially in ankylosing spondylitis, while ICAM-1 did not. #Rheumatology #Spondyloarthritis
https://t.co/DHONGIcRtS

[Armen Yuri Gasparyan @ArmenYuri]

Stroke in autoimmune rheumatic diseases
@YuliyaFedorchen @DDoskaliuk @FedkovDmytro @RusinovichOlga @OlenaZimba @JCRheum @American_Stroke @JSRheumatology
https://t.co/tTOV2sQvcE

[Rheumatology (Bulgaria) @BulgarianR]

How has the history of cytokines shaped the trajectory of modern precision medicine in rheumatic diseases? This comprehensive review traces the evolution from early "pyrogens" to the revolution of targeted biologics and oral JAK inhibitors.
Full text: https://t.co/Gn6rOO13aQ

[Tsvetoslav Georgiev @GeorgievMD]

How did I almost miss the new EULAR recommendations for Behçet’s syndrome? A major 2025 update, from colchicine/apremilast to TNF inhibitors in severe organ disease and, tellingly, TNF is mentioned 79 times! https://t.co/9xNws7tC4M